Skip to main content
. 2016 Jun 14;7(29):45479–45488. doi: 10.18632/oncotarget.9991

Figure 3. Direct comparisons of efficacy between each pair of chemotherapy treatments.

Figure 3

The horizontal lines correspond to the study-specific hazard ratio and 95% confidence interval. The area of the squares reflects the study-specific weight. The diamond represents the results for pooled hazard ratio and 95% confidence interval. (A) Pirarubicin. (B) Epirubicin. (C) Gemcitabine. (D) Mitomycin (C) (E) Thiotepa.